Renal papillary necrosis epidemiology and demographics
|
Renal papillary necrosis Microchapters |
|
Differentiating Renal papillary necrosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Renal papillary necrosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Renal papillary necrosis epidemiology and demographics |
|
FDA on Renal papillary necrosis epidemiology and demographics |
|
CDC on Renal papillary necrosis epidemiology and demographics |
|
Renal papillary necrosis epidemiology and demographics in the news |
|
Blogs on Renal papillary necrosis epidemiology and demographics |
|
Risk calculators and risk factors for Renal papillary necrosis epidemiology and demographics |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
Overview
The prevalence and demographic characteristics of renal papillary necrosis depend on the causative agent.
Epidemiology and Demographics
Prevalence
- Renal papillary necrosis due to analgesic abuse is more prevalent in Australia and England and less in the US. [1]
- In Australia, the prevalence of renal papillary necrosis ranges from 15000 per 100,000 persons to 20000 per 100,000 persons requiring kidney transplant. [1]
- The prevalence of renal papillary necrosis was reported 65,000 per 100,000 patients with sickle cell disease. [2]
- In Africa, the prevalence of symptomatic renal papillary necrosis was reported 2300 per 100,000 patients with sickle cell disease with homozygous S. [3]
Incidence
- In developing countries, the incidence of renal papillary necrosis is 3900 per 100,000 persons.[4]
- The incidence of renal papillary necrosis is 30,000 to 40,000 per 100,000 patients with Sickle cell disease. [5]
Age
- Renal papillary necrosis due to sickle cell disease commonly affects third and fourth decades.[6]
Gender
- Renal papillary necrosis is more prevalent in women.[1][3]
Race
References
- ↑ 1.0 1.1 1.2 Brix AE (2002). "Renal papillary necrosis". Toxicol Pathol. 30 (6): 672–4. doi:10.1080/01926230290166760. PMID 12512867.
- ↑ Pandya KK, Koshy M, Brown N, Presman D (1976). "Renal papillary necrosis in sickle cell hemoglobinopathies". J Urol. 115 (5): 497–501. doi:10.1016/s0022-5347(17)59255-1. PMID 1271537.
- ↑ 3.0 3.1 Madu AJ, Okoye AE, Ajuba IC, Madu KA, Anigbo C, Agu K (2016). "Prevalence and associations of symptomatic renal papillary necrosis in sickle cell anemia patients in South-Eastern Nigeria". Niger J Clin Pract. 19 (4): 471–4. doi:10.4103/1119-3077.183299. PMID 27251962.
- ↑ Dahniya MH, Szmigielski W, Reddy CK, Hanna RM, Cherian MJ, Mattar MS; et al. (1992). "Renal papillary necrosis in Kuwait". Trop Geogr Med. 44 (4): 331–7. PMID 1295143.
- ↑ Alhwiesh A (2014). "An update on sickle cell nephropathy". Saudi J Kidney Dis Transpl. 25 (2): 249–65. doi:10.4103/1319-2442.128495. PMID 24625990.
- ↑ Henderickx MMEL, Brits T, De Baets K, Seghers M, Maes P, Trouet D; et al. (2017). "Renal papillary necrosis in patients with sickle cell disease: How to recognize this 'forgotten' diagnosis". J Pediatr Urol. 13 (3): 250–256. doi:10.1016/j.jpurol.2017.01.020. PMID 28341428.